AGO4
Basic information
Region (hg38): 1:35808016-35857890
Previous symbols: [ "EIF2C4" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the AGO4 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 43 | 43 | ||||
nonsense | 1 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 44 | 0 | 0 |
Variants in AGO4
This is a list of pathogenic ClinVar variants found in the AGO4 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
1-35816908-C-G | not specified | Uncertain significance (Jan 24, 2023) | ||
1-35816911-C-T | not specified | Uncertain significance (May 16, 2025) | ||
1-35816944-A-G | not specified | Uncertain significance (Sep 27, 2024) | ||
1-35817029-G-A | not specified | Uncertain significance (Oct 20, 2024) | ||
1-35822879-T-C | not specified | Uncertain significance (Nov 30, 2021) | ||
1-35822885-G-A | not specified | Uncertain significance (Sep 27, 2024) | ||
1-35822917-C-T | Uncertain significance (May 14, 2020) | |||
1-35822927-A-G | not specified | Uncertain significance (Mar 29, 2022) | ||
1-35822939-G-A | not specified | Uncertain significance (Dec 28, 2024) | ||
1-35822956-C-T | not specified | Uncertain significance (May 01, 2024) | ||
1-35822969-T-C | not specified | Uncertain significance (Dec 04, 2024) | ||
1-35822974-C-G | not specified | Uncertain significance (Mar 01, 2023) | ||
1-35822975-G-A | not specified | Uncertain significance (Dec 07, 2024) | ||
1-35825320-T-C | not specified | Uncertain significance (Dec 12, 2024) | ||
1-35825425-A-G | not specified | Uncertain significance (Aug 08, 2023) | ||
1-35825443-A-T | not specified | Uncertain significance (May 30, 2025) | ||
1-35825463-G-T | not specified | Uncertain significance (May 20, 2025) | ||
1-35825488-C-A | AGO4-related disorder | Uncertain significance (Nov 15, 2022) | ||
1-35825488-C-G | not specified | Uncertain significance (Feb 21, 2024) | ||
1-35825716-G-C | not specified | Uncertain significance (Apr 12, 2025) | ||
1-35825730-C-A | not specified | Uncertain significance (Mar 14, 2023) | ||
1-35825958-A-G | not specified | Uncertain significance (Jun 10, 2025) | ||
1-35826001-A-G | not specified | Uncertain significance (Aug 10, 2024) | ||
1-35826748-G-T | not specified | Uncertain significance (Nov 08, 2024) | ||
1-35826816-C-T | AGO4-related disorder • not specified | Uncertain significance (May 09, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
AGO4 | protein_coding | protein_coding | ENST00000373210 | 18 | 49719 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.00 | 0.000100 | 125728 | 0 | 18 | 125746 | 0.0000716 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 3.79 | 257 | 494 | 0.520 | 0.0000270 | 5631 |
Missense in Polyphen | 56 | 174.99 | 0.32003 | 1980 | ||
Synonymous | 1.64 | 137 | 164 | 0.837 | 0.00000794 | 1689 |
Loss of Function | 5.77 | 5 | 48.2 | 0.104 | 0.00000280 | 515 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000214 | 0.000214 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000166 | 0.000163 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000794 | 0.0000791 |
Middle Eastern | 0.000166 | 0.000163 |
South Asian | 0.0000327 | 0.0000327 |
Other | 0.000166 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Required for RNA-mediated gene silencing (RNAi). Binds to short RNAs such as microRNAs (miRNAs) and represses the translation of mRNAs which are complementary to them. Lacks endonuclease activity and does not appear to cleave target mRNAs. Also required for RNA-directed transcription and replication of the human hapatitis delta virus (HDV). {ECO:0000255|HAMAP- Rule:MF_03033, ECO:0000269|PubMed:15337849, ECO:0000269|PubMed:18552826, ECO:0000269|PubMed:18771919}.;
- Pathway
- Competing endogenous RNAs (ceRNAs) regulate PTEN translation;Signal Transduction;Gene expression (Transcription);Generic Transcription Pathway;Oncogene Induced Senescence;Oxidative Stress Induced Senescence;Cellular Senescence;Cellular responses to stress;RNA Polymerase II Transcription;Pre-NOTCH Transcription and Translation;Pre-NOTCH Expression and Processing;Signaling by NOTCH;TP53 Regulates Metabolic Genes;Cellular responses to external stimuli;Regulation of PTEN mRNA translation;PTEN Regulation;PIP3 activates AKT signaling;Signaling by Nuclear Receptors;Transcriptional Regulation by TP53;Regulation of RUNX1 Expression and Activity;Estrogen-dependent gene expression;ESR-mediated signaling;Intracellular signaling by second messengers;MicroRNA (miRNA) biogenesis;Transcriptional regulation by RUNX1;Small interfering RNA (siRNA) biogenesis;Post-transcriptional silencing by small RNAs;Gene Silencing by RNA
(Consensus)
Recessive Scores
- pRec
- 0.140
Intolerance Scores
- loftool
- rvis_EVS
- -0.89
- rvis_percentile_EVS
- 10.3
Haploinsufficiency Scores
- pHI
- 0.0848
- hipred
- Y
- hipred_score
- 0.756
- ghis
- 0.572
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- gene_indispensability_score
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Ago4
- Phenotype
- cellular phenotype; endocrine/exocrine gland phenotype; reproductive system phenotype;
Gene ontology
- Biological process
- mRNA catabolic process;synaptonemal complex assembly;male meiotic nuclear division;Wnt signaling pathway, calcium modulating pathway;male gonad development;RNA secondary structure unwinding;miRNA metabolic process;positive regulation of gene expression;negative regulation of gene expression;regulation of cell morphogenesis;pre-miRNA processing;posttranscriptional gene silencing by RNA;production of miRNAs involved in gene silencing by miRNA;miRNA mediated inhibition of translation;mRNA cleavage involved in gene silencing by miRNA;miRNA loading onto RISC involved in gene silencing by miRNA;negative regulation of apoptotic process;regulation of megakaryocyte differentiation;mRNA cleavage involved in gene silencing by siRNA
- Cellular component
- P-body;nucleoplasm;cytoplasm;cytosol;membrane;RISC complex;nuclear body;micro-ribonucleoprotein complex;RISC-loading complex
- Molecular function
- double-stranded RNA binding;single-stranded RNA binding;protein binding;miRNA binding